Avestar Capital, LLC Exelixis, Inc. Transaction History

Avestar Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $15,858 - $20,317	-897 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$18.93 - $24.75 $4,751 - $6,212	251 Added 38.85%	897 $19,000
Q1 2019 May 09, 2019	BUY	$19.6 - $24.76 $3,018 - $3,813	154 Added 31.3%	646 $15,000
Q4 2018 Jan 25, 2019	BUY	$13.65 - $21.8 $6,715 - $10,725	492 New	492 $9,000

460

240M

2.04M

1.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $8.23B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.